Home / Articles / Photoinduced anticancer activity of the pyrenebutyrate PtIV prodrug of cisplatin
JUST ACCEPTED ARTICLE. This article has been peer-reviewed and accepted for publication. It is citable and carries a permanent DOI. This version has not been copyedited or typeset and will be replaced by the final version of record.

Photoinduced anticancer activity of the pyrenebutyrate PtIV prodrug of cisplatin

R. Mihaylova 1, 
R. Mihaylova
J. Zaharieva 2, 
J. Zaharieva
G. Momekov 1, 
G. Momekov
Published 13 November 2026 , received 10 July 2026
Communication
0
Cite this
GOST
 | 
Cite this
GOST
Mihaylova R. et al. Photoinduced anticancer activity of the pyrenebutyrate PtIV prodrug of cisplatin // Mendeleev Communications. 2026.
GOST all authors (up to 50)
Mihaylova R., Zaharieva J., Momekov G., Ahmedova A. I. Photoinduced anticancer activity of the pyrenebutyrate PtIV prodrug of cisplatin // Mendeleev Communications. 2026.
RIS
 | 
Cite this
RIS
TY - JOUR
DO - 10.71267/mencom.8145
UR - https://mendcomm.colab.ws/publications/10.71267/mencom.8145
TI - Photoinduced anticancer activity of the pyrenebutyrate PtIV prodrug of cisplatin
T2 - Mendeleev Communications
AU - Mihaylova, R.
AU - Zaharieva, J.
AU - Momekov, G.
AU - Ahmedova, A. I.
PY - 2026
DA - 2026/11/13
PB - Mendeleev Communications
ER -
BibTex
Cite this
BibTex (up to 50 authors)
@article{2026_Mihaylova,
author = {R. Mihaylova and J. Zaharieva and G. Momekov and A. I. Ahmedova},
title = {Photoinduced anticancer activity of the pyrenebutyrate PtIV prodrug of cisplatin},
journal = {Mendeleev Communications},
year = {2026},
publisher = {Mendeleev Communications},
month = {Nov},
url = {https://mendcomm.colab.ws/publications/10.71267/mencom.8145},
doi = {10.71267/mencom.8145}
}
Views / Downloads
128 / 20

Abstract

Asymmetrically disubstituted pyrenebutyrate complex of PtIV was examined as cisplatin prodrugs for its anticancer effects in the dark and upon irradiation against leukemic and colorectal cancer cells. The complex exhibited moderate anticancer activity, which increased two to three-fold after being exposed to UV light (365 nm) for 30 minutes. The study shows that the cytotoxicity of the studied complex is closely linked to its ability to undergo activation either through chemical reduction by biological reductants or through photoinduced processes.

Keywords

activation by reduction
anticancer agents
cytotoxicity
photoactivation
platinum(IV) prodrugs

Funders

Bulgarian National Science Fund
KП-06-H59/9